FI951086A0 - Antivirus-aktiivinen farmaseuttinen öljy-vedessä emulsio, jossa on 9-((2-hydroksietoksi)-metyyli)-guaniniini (asyklovir) tai sen suola tai esteri - Google Patents

Antivirus-aktiivinen farmaseuttinen öljy-vedessä emulsio, jossa on 9-((2-hydroksietoksi)-metyyli)-guaniniini (asyklovir) tai sen suola tai esteri

Info

Publication number
FI951086A0
FI951086A0 FI951086A FI951086A FI951086A0 FI 951086 A0 FI951086 A0 FI 951086A0 FI 951086 A FI951086 A FI 951086A FI 951086 A FI951086 A FI 951086A FI 951086 A0 FI951086 A0 FI 951086A0
Authority
FI
Finland
Prior art keywords
acyclovir
ester
salt
hydroxyethoxy
methyl
Prior art date
Application number
FI951086A
Other languages
English (en)
Swedish (sv)
Other versions
FI951086A (fi
FI112777B (fi
Inventor
Knud Erik Gebhard-Hansen
Soeren Bols Pedersen
Karen Bjoernsdottir
Bodil Gyllembourg Lissau
Boerge Ingvar Frisch Alhede
Original Assignee
Gea Farmaceutisk Fabrik As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gea Farmaceutisk Fabrik As filed Critical Gea Farmaceutisk Fabrik As
Publication of FI951086A0 publication Critical patent/FI951086A0/fi
Publication of FI951086A publication Critical patent/FI951086A/fi
Application granted granted Critical
Publication of FI112777B publication Critical patent/FI112777B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FI951086A 1992-09-09 1995-03-08 Valmistusmenetelmä antivirus-aktiiviselle farmaseuttiselle öljy-vedessä emulsiolle, jossa on 9-[(2-hydroksietoksi)-metyyli]-guaniini (asyklovir) tai sen suola tai esteri FI112777B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DK111392 1992-09-09
DK111392A DK169121B1 (da) 1992-09-09 1992-09-09 Antiviralt virksom farmaceutisk olie-i-vand-emulsion indeholdende 9-[(2-hydroxyethoxy)methyl]guanin (acyclovir) eller et salt eller en ester deraf
DK9300288 1993-09-09
PCT/DK1993/000288 WO1994005258A1 (en) 1992-09-09 1993-09-09 An antivirally active pharmaceutical oil-in-water emulsion containing 9-[(2-hydroxyethoxy)methyl]guanine (acyclovir) or a salt or ester thereof

Publications (3)

Publication Number Publication Date
FI951086A0 true FI951086A0 (fi) 1995-03-08
FI951086A FI951086A (fi) 1995-03-08
FI112777B FI112777B (fi) 2004-01-15

Family

ID=8101156

Family Applications (1)

Application Number Title Priority Date Filing Date
FI951086A FI112777B (fi) 1992-09-09 1995-03-08 Valmistusmenetelmä antivirus-aktiiviselle farmaseuttiselle öljy-vedessä emulsiolle, jossa on 9-[(2-hydroksietoksi)-metyyli]-guaniini (asyklovir) tai sen suola tai esteri

Country Status (27)

Country Link
EP (1) EP0662819B1 (fi)
JP (1) JPH08501089A (fi)
AT (1) ATE137113T1 (fi)
AU (1) AU4945393A (fi)
BG (1) BG62032B1 (fi)
BR (1) BR9307024A (fi)
CA (1) CA2142493A1 (fi)
CZ (1) CZ284007B6 (fi)
DE (1) DE69302396T2 (fi)
DK (1) DK169121B1 (fi)
EE (1) EE03088B1 (fi)
ES (1) ES2086235T3 (fi)
FI (1) FI112777B (fi)
GR (1) GR3019984T3 (fi)
HR (1) HRP931160B1 (fi)
HU (1) HUT72606A (fi)
LT (1) LT3056B (fi)
LV (1) LV10912B (fi)
NO (1) NO308234B1 (fi)
PL (1) PL172663B1 (fi)
RO (1) RO113306B1 (fi)
RU (1) RU2128503C1 (fi)
SI (1) SI9300469A (fi)
SK (1) SK280119B6 (fi)
UA (1) UA41897C2 (fi)
WO (1) WO1994005258A1 (fi)
ZA (1) ZA936661B (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4416674C2 (de) * 1994-05-11 1997-01-30 Rentschler Arzneimittel Topische Zubereitung enthaltend Aciclovir
ZA96525B (en) * 1995-02-06 1996-08-06 Astra Ab Novel pharmaceutical compositions
US6440980B1 (en) 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
AU2004202929B2 (en) * 1999-09-22 2006-11-23 B. Ron Johnson Systems for agitated delivery of anti-infective compositions to treat disordered tissue such as cold sores
WO2005067941A1 (es) * 2004-01-08 2005-07-28 Universidad De Concepcion Formulacion topica de aciclovir
WO2005102282A1 (en) * 2004-04-19 2005-11-03 Strategic Science & Technologies, Llc Transdermal delivery of beneficial substances effected by a hostile biophysical environment
US20050257718A1 (en) * 2004-05-22 2005-11-24 Engelhard Corporation Natural Pearl in Butylene Glycol
US8927015B2 (en) 2006-04-12 2015-01-06 Emisphere Technologies, Inc. Formulations for delivering insulin
US20120142623A1 (en) * 2006-07-07 2012-06-07 Michael Lagunoff Compositions And Methods For Predicting Inhibitors Of Protein Targets
US11684624B2 (en) 2009-06-24 2023-06-27 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
MX337166B (es) 2009-06-24 2016-02-15 Composicion topica que contiene ibuoprofeno.
CN103429247A (zh) 2010-12-29 2013-12-04 战略科学与技术有限责任公司 勃起功能障碍和其它适应症的治疗
US9549930B2 (en) 2013-03-14 2017-01-24 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered and/or prodromal stage tissue
US9463180B2 (en) 2013-03-14 2016-10-11 Quadex Pharmaceuticals, Llc Treatment of molluscum contagiosum
US9125911B2 (en) 2013-03-14 2015-09-08 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered tissues
FR3023718B1 (fr) * 2014-07-16 2018-10-12 Pierre Fabre Medicament Compositions pharmaceutique et/ou cosmetique decontaminees par haute pression
GB201819418D0 (en) 2018-11-29 2019-01-16 Daniel Calladine Ltd Anti-viral compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523865A (en) 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof
GB2080106B (en) * 1980-07-18 1984-03-07 Weelcome Foundation Ltd Acyclovin preparations

Also Published As

Publication number Publication date
DK111392D0 (da) 1992-09-09
ZA936661B (en) 1994-05-20
AU4945393A (en) 1994-03-29
NO308234B1 (no) 2000-08-21
HRP931160A2 (en) 1995-12-31
SI9300469A (en) 1994-03-31
LV10912A (lv) 1995-12-20
EP0662819A1 (en) 1995-07-19
DE69302396T2 (de) 1996-08-14
RU95110930A (ru) 1997-03-27
RU2128503C1 (ru) 1999-04-10
WO1994005258A1 (en) 1994-03-17
CZ284007B6 (cs) 1998-07-15
LTIP959A (en) 1994-05-15
HU9500702D0 (en) 1995-04-28
PL307860A1 (en) 1995-06-26
BR9307024A (pt) 1999-06-29
FI951086A (fi) 1995-03-08
EP0662819B1 (en) 1996-04-24
PL172663B1 (pl) 1997-10-31
ES2086235T3 (es) 1996-06-16
NO950895L (no) 1995-03-08
UA41897C2 (uk) 2001-10-15
HUT72606A (en) 1996-05-28
CZ59995A3 (en) 1995-09-13
DK111392A (da) 1994-03-10
DE69302396D1 (de) 1996-05-30
SK280119B6 (sk) 1999-08-06
EE03088B1 (et) 1998-06-15
JPH08501089A (ja) 1996-02-06
CA2142493A1 (en) 1994-03-17
SK29195A3 (en) 1997-01-08
LT3056B (en) 1994-10-25
RO113306B1 (ro) 1998-06-30
ATE137113T1 (de) 1996-05-15
BG99484A (bg) 1995-12-29
FI112777B (fi) 2004-01-15
DK169121B1 (da) 1994-08-22
HRP931160B1 (en) 1999-04-30
NO950895D0 (no) 1995-03-08
BG62032B1 (bg) 1999-01-29
GR3019984T3 (en) 1996-08-31
LV10912B (en) 1996-08-20

Similar Documents

Publication Publication Date Title
FI951086A0 (fi) Antivirus-aktiivinen farmaseuttinen öljy-vedessä emulsio, jossa on 9-((2-hydroksietoksi)-metyyli)-guaniniini (asyklovir) tai sen suola tai esteri
US4963555A (en) Formulations of heterocyclic compounds
KR890006213A (ko) 토코페롤 소르베이트를 함유하는 광보호 조성물
RU2000112410A (ru) Стабильные косметические композиции
IE811617L (en) Topical formulations of 9-(2-hydroxyethoxymethyl) guanine
EP0593562B1 (en) Topical composition containing penciclovir
CA2074503C (en) Pharmaceutical formulation containing penciclovir
CA2022632A1 (en) Pharmaceutical formulation
US6469015B1 (en) Pharmaceutical formulation
TH68541A3 (th) องค์ปรกอบของแอซิโคลเวอร์ที่มีไดเมทิโคน